FMRP dependent synaptic delivery of messenger RNA by Kao, Der-I
FMRP DEPENDENT SYNAPTIC DELIVERY OF MESSENGER RNA 
 
 
 
 
 
 
 
 
BY 
 
DER-I KAO 
 
 
 
 
 
 
 
 
DISSERTATION 
 
Submitted in partial fulfillment of the requirements 
for the degree of Doctor of Philosophy in Cell and Developmental Biology 
in the Graduate College of the 
University of Illinois at Urbana-Champaign, 2010 
 
 
 
 
 
 
Urbana, Illinois 
 
 
 
Doctoral Committee: 
 
Professor Jie Chen, Chair 
Associate Professor Charles L Cox, Director of Research 
Professor William T Greenough, Director of Research 
Associate Professor Philip A Newmark 
Associate Professor Stephanie Ceman 
ii 
 
Abstract 
 
Fragile X mental retardation is the most common inherited form of mental retardation. 
The loss of FMRP function results in Fragile X Mental Retardation. In this dissertation, I 
investigated the regulatory role of FMRP involved in synaptic mRNA delivery. 
In chapter 1, the molecular mechanism of local protein synthesis and synaptic mRNA 
delivery and its roles in Fragile X syndrome and learning and memory are introduced. In 
chapter 2, my data demonstrated that FMRP can facilitate mRNA deceleration and 
localization in dendritic spines upon neurotransmitter stimulation. Consistent with these 
findings, local protein synthesis was also enhanced in dendritic spines after stimulation. 
These results suggested that FMRP could mediate synaptic mRNA delivery for local 
protein synthesis. In Chapter 3, the role of FMRP splicing isoforms in synaptic mRNA 
delivery was investigated. My data suggested phosphorylation regulation and multiple 
isoforms of FMRP will be required to restore mRNA targeting to dendritic spines. 
In conclusion, synaptic mRNA delivery regulated by FMRP isoforms was demonstrated 
as a novel mechanism underlying altered cognitive deficits associated with Fragile X 
Syndrome. When mRNA cannot be targeted properly for translation, it may result in 
deficits in spine structure and neurological phenotypes, such as Fragile X Syndrome. My 
research also corroborates the importance of spatial accuracy of protein synthesis at a 
microscopic level in the nervous system.  
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Chapter 1. 
Background 
 
Fragile X Syndrome. 
Fragile X Syndrome (FXS) is the most common form of inherited mental retardation and 
is caused by the loss of function of the FMR1 gene, which encodes fragile X mental 
retardation protein (FMRP) [1]. FXS affects 1 in 4000 males and 1 in 6000 females on 
average and is characterized by hyperactivity, attention deficits, autistic like behaviors, 
seizures, and in males macroorchidism [2]. The molecular basis of fragile X syndrome 
has been determined. The expansion of CGG repeats (230 to more than 1000 copies) in 
Fragile X individuals results in the concomitant methylation of the putative CpG island 
promoter region located 250bp upstream with subsequent abolition of FMR1 
transcription [3-5]. The absence of FMR-1 mRNA and consequent FMRP expression is 
the cause for the disorder since FMRP expression is highly enriched in the normal brain 
and testis, which are relevant to the clinical phenotype [6]. 
Mental impairment related phenotypes in Fragile X Syndrome have been studied 
extensively since the fmr1 knockout mouse model was generated [7]. Dendritic spine 
morphology in the cerebral cortex of FXS patients and in the fmr1 KO mouse model 
shows more immature long thin spines than mature stubby, mushroom-shaped spines 
during development [8]. Interestingly, spine morphology is also altered in other genetic 
disorders causing mental retardation, such as Down syndrome [9]. Furthermore, group I- 
metabotropic glutamate receptor (mGluR) dependent long term depression (LTD) in the 
hippocampus is exaggerated in the fmr1 KO model and this has been shown to be 
associated with glutamate receptor subunit, GluR1, internalization [10]. These findings 
suggest that FMRP functions in synaptic development and plasticity. 
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Protein synthesis dependent synaptic plasticity in neurons. 
Local protein synthesis at synapses is the mechanism to provide synapse-dependent 
changes localized to the stimulation source. Neurons have a highly polarized cell 
structure and typically one long axon and multiple dendrites. Dendrites differ from axons 
morphologically and functionally. The synapse is the specialized structure that allows 
communicating between two neurons. Their communication is both through chemicals 
(neurotransmitters) and through electrical current. The pre-synaptic compartment 
contains synaptic vesicles filled with neurotransmitter, which are ready to release into the 
synaptic cleft when the membrane is depolarized by an action potential. Subsequently, 
both ionotropic and metabotropic neurotransmitter receptors on the post-synaptic 
compartment, closely apposing to the presynaptic compartment, are activated by 
neurotransmitters. The activation of these receptors can cause protein synthesis or post-
translational modification in the post-synaptic compartment to modify the molecular 
contents for synaptic plasticity establishment or maintenance. Persistent, activity-
dependent changes at individual synapses are a mechanism, termed synaptic plasticity, by 
which the brain encodes and stores information. Synaptic plasticity can also involve the 
alteration of electrophysiological and structural properties of a synapse. Previous studies 
have shown that activity-dependent local translation is a fundamental mechanism 
underlying synaptic plasticity [11, 12]. Inhibition of protein synthesis attenuates specific 
types of synaptic plasticity and learning behaviors [13-16]. Strikingly, animals lacking 
dendritic CaMKII mRNA and protein had reduced long-term potentiation (LTP) and 
impaired memory performance [17]. Morphological changes in dendritic spines can also 
be blocked by protein synthesis inhibitors [18]. These data suggest that local protein 
synthesis of dendritic mRNA at activated synapses is critical to maintain synaptic 
function and structure underlying learning and memory. 
 
Evidence of synaptic protein synthesis. 
The regulation of polyribosome and mRNA delivery to synapses is the key determinant 
to produce specific protein in a single synapse to modify local synaptic strength. Early 
studies found that polyribosomes and certain mRNA are identified in dendritic 
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compartment in addition to the neuronal cell body [19-21]. By using electron microscopy, 
Steward et al. found that most synapses have closely associated polyribosomes during 
periods of maximal synaptogenesis, implying that local protein synthesis is very 
important during periods of synapse growth [22]. Interestingly, the thickness of the 
postsynaptic density in the sensorimotor area is positively correlated with the number of 
ribosomal inclusions [23]. Following synaptic stimulation leading to LTP in the CA1 
region of the hippocampus, polyribosomes appear to relocate from the base of the spine 
into the spine head [24]. The data suggest that synaptic localization of polyribosomes is 
regulated by neuronal activity and highly correlates with positions of increased 
translational capacity. 
Dendritic mRNAs have been identified by in situ hybridization and biochemical isolation 
of synaptoneurosomes or synaptodendrosomes, which are the subcellular fractions 
enriched with axon and postsynaptic connections [21]. Since dendritic localization in the 
hippocampus and the cerebellar cortex can be recognized by distinct neuropil layers that 
contain dendrites but few neuronal cell bodies, in situ hybridization on tissue sections 
provide good spatial orientation to identify dendritic mRNAs. Dendritic localization of 
MAP2 [25], CaMKII, Arc/Arg3.1 [27] and other mRNAs were identified by using 
in situ hybridization. For biochemical approaches, FMRP [12] and CaMKII [28] were 
identified in synaptoneurosomes to be translated in response to glutamate receptors 
(NMDA or group I mGluR) activation. The pool of dendritic mRNAs encodes a 
multitude of synaptic proteins: scaffolding proteins (such as PSD-95), protein kinases 
(such as CaMKII), receptors (such as GluR1, one subunit of AMPA receptor), 
cytoskeleton associating proteins (such as MAP2), transcription factors (such as CREB), 
and others [29]. The evidence further corroborates the presence of selective mRNAs in 
neuronal dendrites as well as synapses. 
Protein synthesis present in local compartments was established in synaptoneurosomes 
and isolated dendrites. Weiler et al. demonstrated a rapid polysome-association pattern of 
Fmr1 mRNA and production of FMRP in synaptoneurosomes after group I mGluR 
stimulation [12]. Local incorporation of radio-labeled amino acid was also demonstrated 
in physically isolated dendrites [30]. In two independent studies using visually isolated 
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dendrites, authors showed that there are protein synthesis hotspots in close proximity of 
ribosomes following group I mGluR or BDNF activation [31, 32]. In a higher resolution 
experiment using electron microscopy, Krichevsky et al. elegantly demonstrated that 
depolarization reorganizes biochemically isolated mRNA granules and induces a less 
compact structure of their ribosomes [33]. Therefore, protein synthesis and the 
association between polyribosome and mRNA are tightly regulated by neuronal activity. 
 
Molecular machinery of dendritic mRNA transport. 
The coordinate mechanism of RNA localization and local translation has been 
extensively studied as it allows spatio-temporal modulation of local protein repertoires. In 
Xenopus oocytes, Vg1, a member of the transforming growth factor- family involved in 
mesoderm induction, can only be translated subsequent to the localization of its mRNA to 
the vegetal pole [34]. Elevated gradient of Nanos protein in the posterior pole of the 
Drosophila embryo establishes antero-posterior patterning. This gradient results from 
both nanos mRNA translational repression in the bulk of the embryo and translational 
activation of nanos mRNA localized at the posterior pole [35]. RNA transport is 
particularly important to neurons due to the complexity of their intracellular 
compartments and the use of local translation in these compartments for focal regulation 
of development and synaptic strength [36]. Localized mRNAs are transported in large 
ribonucleoprotein complex particles (RNPs), which have been referred as RNA granules. 
Neuronal RNA granules often contain specific RNA binding proteins, mRNAs, adaptors 
connecting RNA binding proteins and motor proteins, and motor proteins despite 
diversity of composition and function among granules [37]. 
The molecular content and involvement in local mRNA translation of neuronal RNA 
granules have been intriguing in neuroscience field. Neuronal RNA granules originate in 
the nucleus because of the presence of hnRNPs, splicing components, exon-junction 
complex (EJC) proteins and other nuclear proteins [36]. Functionally, splicing events 
could be regulated and occur in distal dendrites in order for alternate splicing variants to 
be translated [38, 39]. Moreover, nonsense-mediated decay (NMD) can be carried out in 
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neuronal dendrites to restrict spatial and temporal protein expression [40]. The transport 
of mRNA is tightly coupled to the repression of translation at the step of translation 
initiation or elongation. Sossin et al. [36] defined RNA transport particles as the transport 
complex containing no ribosomes. In RNA transport particles, mRNAs have no access to 
ribosome until they are released from the complex. Therefore, translation of mRNAs in 
transport particles is repressed in the initiation stage. On the other hand, some RNA 
granules contain large and small ribosomal subunits. Translation is also repressed in these 
structures but at the elongation stage. As described in Krichevsky et al, by using electron 
microscopy they identified RNA granules as a macromolecular structure, which are 
highly enriched in Staufen (an RNA binding protein) and contain densely packed clusters 
of ribosomes. Depolarization reorganizes granules and induces a less compact 
organization of their ribosomes [33]. The reorganization process in response to 
depolarization suggests that mRNA and ribosomes are released from highly compact 
repression structures and become accessible to each other, and then translationally active. 
Interestingly, while expression of phosphorylated FMRP on serine 499 leads to an 
increase in stalled polyribosomes, non-phosphorylated FMRP loses the ability, 
suggesting that its dephosphorylation may lead to the release of polyribosomes from the 
stalled state [41]. The data suggests that FMRP could be involved in the transition 
between translation repression and de-repression. 
Protein components of neuronal RNA granules have also been investigated 
systematically. Kanai et al [42] isolated a RNase-sensitive granule (1000S~) as a binding 
partner of KIF5 (kinesin heavy chain). After analysis by 2D-gel and MS/MS, the granule 
contains 42 proteins including those for RNA transport (such as FMRP, Pur and Staufen), 
protein synthesis (such as EF-1 and eIF2), RNA helicase, and other RNA associated 
functions. In a proteomics study, RNA granule enriched fraction was also purified from 
rat embryonic day 18 brains. Abundant protein components of this fraction are 
determined by tandem mass spectrometry. Although the isolated proteins are not exactly 
the same as those identified in Kanai et al, they also include ribosomal proteins, RNA-
binding proteins, and motor proteins [43]. These studies provide a broader view of RNA 
granule components and their implication in RNA transport and delivery. 
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Synaptic targeting of mRNAs. 
Enduring synaptic modification requires the selective delivery of new mRNA transcripts 
to the synapses that are to be modified. Synaptic targeting of Arc (activity-regulated 
cytoskeleton-associated protein) mRNA is the best-studied synaptic delivery model to 
date. Steward et al. [44] elegantly presented that high frequency activation of the afferent 
perforant path projections to the dentate gyrus results in newly synthesized Arc mRNA to 
selectively localized in activated dendritic segments. At the same time, Arc protein also 
accumulates in the portion of the dendrite that had been synaptically activated. By 
applying local pharmaceutical treatment, it is further confirmed that synaptic targeting of 
Arc mRNA requires NMDA receptor activation, ERK phosphorylation and actin 
polymerization [45, 46]. It suggests that signaling network and actin organization are 
critical to localize and anchor mRNA to activated synapses. This series of studies shed 
light on the physiological significance of synaptic targeting of selective mRNAs. 
Dendritic spines, where actin is the major cytoskeletal elements, are the specialized 
structure of excitatory synapses. There are other studies using dendritic spines as local 
synaptic targets of mRNA docking after excitatory stimulation. TLS (translocated in 
liposarcoma)-containing mRNP complexes can associate with myosinV and be targeted 
to spines following group I mGluR activation. In the presence of a dominant negative 
form of myosinV, the TLS complex failed to be translocated into spines [47]. 
Interestingly, following group I mGluR stimulation, FMRP-containing mRNP complex 
could move into spines as shown by colocalization with PSD-95 and Shank proteins [48]. 
However, because PSD-95 and Shank could also appear in the dendritic shaft, the 
localization of FMRP containing mRNP complex in dendritic spines needs to be further 
characterized. Polyribosomes also relocate to dendritic spines in response to tenatic 
stimulation [24, 49], although they preferentially localize under the base of dendritic 
spines before stimulation [50]. In summary, these previous studies suggest that both 
ribosomes and mRNAs can be delivered to dendritic spines. The process of synaptic 
mRNA docking is possibly mediated by coordinating RNA transport granules dynamics, 
mRNA association with myosin motor proteins, and activation of actin organization. 
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Local protein synthesis regulated by FMRP. 
FMRP is a ribosome-associated protein also with selective affinity to mRNAs [51-54]. 
Local production of specific proteins is critical for enduring synaptic modification. For 
instance in the fmr1 KO model, it has been shown that aberrant synthesis of individual 
proteins such as CaMKII, PSD-95 and MAP1b, following group 1 mGluR stimulation, 
is associated with defective long-term synaptic plasticity [55-57]. Additionally, AMPA 
receptor internalization, necessary for regulating synaptic strength, is also affected by the 
dysregulated protein synthesis in fmr1 KO neurons [14, 58, 59]. Emerging evidence 
indicates that RNA binding proteins, ribosomes, translation factors and mRNAs encoding 
proteins critical to synaptic structure and function localize to neuronal processes [42]. 
FMRP, mRNA and other RNA binding proteins can form RNP (ribonucleoprotein) or 
granule structures and couple with motor proteins to be transported in dendrites [42, 60, 
61]. RNAs are transported into dendrites in a translationally quiescent state where 
translation mechanisms are activated by synaptic stimuli [62-64]. Dendritic transport of 
FMRP and associated mRNAs, such as Fmr1, CaMKII, and MAP1b, are regulated by 
group I mGluR signaling [63, 65]. However, it is not yet fully understood how and when 
mRNA is delivered to the synapse and translated. Local delivery of mRNA to active 
synapses could provide a high degree of regulation and flexibility of protein synthesis 
[24, 31, 32, 50, 66]. The molecular mechanism of FMRP mediated mRNA delivery 
implicated in synaptic plasticity is investigated in this thesis. 
 
FMRP associated mRNAs. 
FMRP is identified as an RNA binding protein containing two KH domains, first 
described in hnRNP K protein, and one RGG box, an arginine- glycine- rich region found 
in a variety of nuclear and nucleolar proteins [67]. The identity and function of mRNAs 
associating with FMRP has attracted major interest in the field. Fmr1 mRNA is the first 
reported FMRP associated mRNA with strong affinity to FMRP [51]. Later in 2001, there 
were two microarray articles reporting the pool of mRNA associated with FMRP. 
Miyashiro et al [53] developed antibody-positioned RNA amplification (APRA), to 
identify the RNA cargoes associated with the in vivo configured FMRP messenger 
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ribonucleoprotein (mRNP) complex in intact neurons. Among all RNA candidates, 
RGS5, DAG1 (dystroglycan associated glycoprotein 1) and GR (glucocorticoid receptor 
) show different subcellular distribution in the Purkinje neurons of fmr1 KO cerebellum 
than in wild type. In later independent studies, the regulatory role of FMRP in RGS5, 
GABAA receptor- subunit [65] and Rab3a [68] was further confirmed. Brown et al [54] 
utilized immunoprecipitation to identify mRNAs in FMRP-mRNP complexes. The 
association between MAP1b [57], SAPAP4 [65] and semaphorin 3F [69, 70] and FMRP 
was further confirmed by later studies. From both results, a large number of candidate 
genes encoding cell signaling molecules, cytoskeleton/cell structure components and 
receptor subunit were retrieved. It suggests that the lack of FMRP in Fragile X Syndrome 
patients can lead to dysregulated synaptic expression of its many associated mRNAs, 
which could account for subsequent plasticity deficits. However, there is no overlap of 
RNA candidates between these two studies and Fmr1 mRNA was not identified. 
Therefore, more systematic studies are still ongoing in other labs. 
There are also a lot of studies focusing on investigating FMRP-associated mRNAs and 
their roles in synaptic plasticity. Ca
2+
/calmodulin-dependent protein kinase II subunit  
(CaMKII), in a calcium and calmodulin dependent manner, phosphorylates many 
different brain substrates including synapsin I, tyrosine hydroxylase and nitric oxide 
synthase. Therefore, CaMKII is able to perform regulatory functions associated with 
increases in intracellular free calcium. Its activity is also involved in modulating AMPA 
and NMDA receptor-mediated synaptic transmission [71]. CaMKII is highly enriched 
in the postsynaptic density of hippocampus and neocortex [72] and its protein level is 
elevated upon synaptic stimulation [28, 73]. By using genetic models, it has been shown 
that CaMKII is involved in both long-term potentiation (LTP) and long-term depression 
(LTD) events depending on stimulation paradigm and brain regions [74, 75]. FMRP can 
regulate CaMKII protein levels following group I mGluR stimulation [55]. In fmr1 KO 
neurons, dendritic transport of CaMKII mRNA in response to stimulation is impaired 
[65]. Therefore, in the absence of FMRP, CaMKII protein cannot be expressed properly 
to carry out its kinase activity for subsequent synaptic events. 
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PSD-95 (postsynaptic density protein 95) is a scaffolding protein containing PDZ 
domains that provide association with receptors and cytoskeletal elements at synapses. 
PSD-95 is also involved in maturation of excitatory synapses [76]. It has been shown that 
FMRP regulates PSD-95 protein synthesis by mediating PSD-95 mRNA association with 
polyribosomes at synapses [56, 64]. The evidence suggests that in the absence of FMRP 
in Fragile X syndrome, PSD-95 mRNA cannot associate with polyribosomes or be 
translated efficiently for the maintenance of the structure of excitatory synapses. 
MAP1b (microtubule-associated protein 1b) controls neurite extension and growth cone 
motility via modulating microtubule dynamics [77]. MAP1b may be also involved in 
group I mGluR induced AMPA receptor endocytosis to alter synaptic strength [78]. In 
fmr1 KO neurons, the aberrant MAP1b expression during development leads to 
abnormally increased microtubule stability [57]. FMRP is able to associate with MAP1b 
mRNA and regulate its dendritic transport [65, 79]. These results suggest that FMRP 
controls MAP1b translation to modulate the dynamic organization of neuronal 
cytoskeleton and synaptic connections, and the abnormal microtubule stability caused by 
FMRP deficiency could contribute to the impaired synaptic maturation in Fragile X 
Syndrome. 
 
FMRP isoforms. 
FMR1 pre-mRNA has four alternative splicing sites and can give rise to as many as 24 
different mRNAs and to 24 possible corresponding proteins (Figure 1.1) [80-82]. The 
functions carried out by individual FMRP isoforms or by their interaction are poorly 
understood because the majority of our knowledge regarding Fragile X Syndrome is 
based on fmr1 knockout model, in which all isoforms are missing. Therefore, it could be 
of important clinical relevance to understand if different isoforms are associated with 
distinct functions. To also better assess the possibility of gene therapy for Fragile X 
Syndrome, we have to understand FMRP isoform functions in greater detail. The first 
alternative spicing site of Fmr1 around exon12 creates iso-1, including exon12, and iso-7, 
lacking exon12 (Figure 1.1). The second alternative spicing site utilizes three alternative 
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splice acceptor sites on exon15 (ex15a, ex15b, or ex15c) with exon14 included or 
excluded to produce 6 splicing variants (Figure 1.1). The predicted mRNA including 
exon14 are referred as Fmr1 iso-2 (alternate acceptor b, exon15b) and Fmr1 iso-3 
(alternate acceptor c, exon15c), and the corresponding isoforms lacking exon12 would be 
referred to as Fmr1 iso-8 and iso-9. Similarly, exon14 is spliced out on iso-4, 5, 6, 10, 11, 
and 12. The exclusion of exon14 from Fmr1 message causes the loss of nuclear export 
signal (NES) and a +1 frame shift in the Fmr1 reading frame downstream of the splicing 
site. Since the Fmr1 isoforms lacking exon14 will be restricted inside the nucleus [83], 
their dendritic localization and function will not be studied here. The last alternative 
splicing occurs to include or exclude a 5’ fragment of exon17 (Figure 1.1). Because there 
is no important functional domain on exon17, these isoforms were poorly studied. 
The diversity of FMRP isoforms containing or lacking exon12 in conjunction with using 
different exon15 splicing acceptors could contribute to a pool of proteins with distinct 
functions in neuronal dendrites. Exon12 encodes a hydrophobic loop in the KH2 domain, 
one of three RNA binding sites on FMRP, which has preferential affinity with kissing 
complex RNA [82]. Exon12 variant proteins might differentially associate with kissing 
complex in vitro [84]. Therefore, the presence or absence of exon12 could affect selective 
RNA binding affinity of FMRP. The exon15 splicing variants can be differentially 
phosphorylated and methylated and possibly result in distinct RNA binding preference 
[84-86]. In adult and embryonic stages, FMRP isoforms without exon12 are more 
abundant than those containing exon12; FMRP isoforms containing full length exon15 
(Ex15a) are more abundant than other spliced forms [84]. To add to this limited 
information, I will examine dendritic function of four specific FMRP isoforms (Figure 
1.1). 
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Figures  
Figure 1.1 Alternative splicing of Fmr1. 
(a) Fmr1 exons (8-17) represented by boxes. A full length Fmr1 mRNA (blue) is 
represented with corresponding functional domains (red) and alternative splicing sites 
(black lines). Three RNA binding domains, KH1, KH2, and RGG, nuclear export signal 
(NES), and phosphorylation site (S499) are indicated.  
(b) Fmr1 mRNAs of iso1-iso12 are represented. Iso1, 2 and 3 use alternative splicing 
acceptor of exon15 a, b, or c. Besides the variation in exon15 acceptor sites, iso7, 8 and 9 
do not contain exon12. Iso4, 5, and 6 have similar exon15 splicing acceptor variations but 
use 5’end of exon14 as the splicing donor. Therefore, the event to splice out exon14 
(containing NES) causes the protein to be restricted to the nucleus and also causes a 
frame shift downstream of exon14. Iso10, 11, and 12 have the same variation in exon14 
and 15 as iso4, 5, and 6 but they do not contain exon12. The study of isoform function in 
synaptic mRNA targeting will be focused on iso1, 2, 7, and 8, as circled on the diagram. 
 
 a. 
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Figure 1.1 Alternative splicing of Fmr1. (cont.) 
 
b. 
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Chapter 2. 
Altered mRNA transport, docking, and protein translation in neurons lacking 
fragile X mental retardation protein 
(Data presented here were originally published in Proc Natl Acad Sci U S A. 2010 Aug 
31; 107(35):15601-6.) 
 
Abstract 
Fragile X syndrome is caused by the absence of functional fragile X mental retardation 
protein (FMRP), an RNA binding protein. The molecular mechanism of aberrant protein 
synthesis in fmr1 KO mice is closely associated with the role of FMRP in mRNA 
transport, delivery, and local protein synthesis. We show that GFP labeled Fmr1 and 
CaMKII mRNAs undergo decelerated motion at 0-40 minutes after group I mGluR 
stimulation, and later recover at 40-60 minutes. Based on this finding, we investigate 
targeting of mRNA associating with FMRP after neuronal stimulation. We find that 
FMRP is synthesized closely adjacent to stimulated mGluR5 receptors. Moreover, in WT 
neurons, CaMKII mRNA can be delivered and translated in dendritic spines at early 
time points in response to group I mGluR stimulation, whereas KO neurons fail to show 
this response. Lastly, GluR1 internalization occurs after stimulation in spines of WT 
neurons but instead is constitutively internalized in the dendrites of fmr1 KO neurons. 
These data suggest that FMRP can mediate spatial mRNA delivery for local protein 
synthesis to establish plasticity in response to synaptic stimulation. 
 
Introduction 
Fragile X syndrome (FXS) is the most common form of inherited mental retardation and 
is caused by the loss of function of the FMR1 gene, which encodes fragile X mental 
retardation protein (FMRP) [1]. FXS affects 1 in 4000 males and 1 in 6000 females on 
average and is characterized by hyperactivity, attention deficits, autistic like behaviors, 
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and seizures [2]. Dendritic spine morphology in the cerebral cortex of FXS patients and 
in the fmr1 KO mouse model shows more immature long thin spines than mature stubby, 
mushroom-shaped spines [8]. Furthermore, group I-mGluR dependent long term 
depression (LTD) in the hippocampus is exaggerated in the fmr1 KO model and this has 
been shown to be associated with GluR1 internalization [10]. These findings suggest that 
FMRP functions in synaptic development and plasticity. 
Activity-dependent local translation is a fundamental mechanism underlying synaptic 
plasticity [11, 12]. Inhibition of protein synthesis attenuates specific types of long-term 
plasticity [13, 14]. Morphological changes in dendritic spines can also be blocked by 
protein synthesis inhibitors [18]. Local production of specific proteins is critical for 
enduring synaptic modification: for instance in the fmr1 KO model, it has been shown 
that aberrant synthesis of individual proteins such as CaMKII, PSD-95 and MAP1b, 
upon group 1 mGluR stimulation, is associated with defective long-term plasticity [55-
57]. Additionally, AMPA receptor internalization, necessary for regulating synaptic 
strength, is also affected by the dysregulated protein synthesis in fmr1 KO neurons [14, 
58, 59]. Here, we have studied specific molecular mechanisms that may elucidate 
aberrant translation in the fmr1 KO model. 
The molecular basis of FMRP’s role in translation dependent plasticity remains unclear 
despite extensive study. FMRP is a ribosome-associated RNA binding protein with 
selective affinity [51-54]. Upon neuronal stimulation, FMRP may regulate protein levels 
by mediating translational regulation and mRNA trafficking [63, 64]. FMRP, mRNA and 
other RNA binding proteins can form RNP (ribonucleoprotein) or granule structures and 
couple with motor proteins to be transported in dendrites [42, 60, 61]. Dendritic transport 
of FMRP and associated mRNAs, such as Fmr1, CaMKII, and MAP1b, are regulated 
by group I mGluR signaling [63, 65]. Studies have shown that Arc mRNA can be 
targeted to active synapses upon high frequency stimulation in the perforant pathway [44, 
87].  However, it is not yet fully understood how and when mRNA is delivered to the 
synapse and translated. Local delivery of mRNA to active synapses could provide a high 
degree of regulation and flexibility of protein synthesis [24, 31, 32, 50, 66]. 
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We hypothesized that FMRP regulates dendritic mRNA dynamic motions leading to local 
protein synthesis and subsequent plasticity in response to neuronal stimulation. We 
investigated the speed and directionality of mRNA movement upon group I mGluR 
stimulation using time-lapse imaging of cultured WT and fmr1 KO neurons. We found 
that at 0-40 minutes after stimulation the speed of mRNA containing granules showed a 
reduction in WT but not KO dendrites, and at 40-60 minutes mRNAs resumed more 
directional motion. In the early time points after stimulation, FMRP was also translated in 
regions closely adjacent to mGluR5. CaMKII mRNAs and proteins were more enriched 
at dendritic spines in WT, but not fmr1 KO neurons. Interestingly, we showed GluR1 
internalization occurred at spines after stimulation in WT neurons but remained 
constitutively internalized in the dendrites of KO neurons. This suggests the lack of local 
translation regulation and translation-dependent plasticity in fmr1 KO neurons could 
originate from the aberrant mRNA targeting function in the absence of FMRP. 
 
Materials and Methods 
DNA constructs.  
The GFP-MS2-nls and MS2 binding site-CaMKII 3’UTR constructs were kindly 
provided by Dr. Kenneth S. Kosik, UCSB. MS2bs vector was generated from MS2bs-
CaMKII 3’UTR by removing CaMKII 3’UTR using BglII and NotI. MS2bs-Fmr1 
was constructed by insertion of the Fmr1 ORF (open reading frame) and 3’UTR 
(untranslated region) PCR fragment into an MS2bs vector. The Fmr1 fragment was 
generated from Mc2.17 by PCR and digestion with BamHI and NotI. All plasmids were 
sequenced to verify their composition. 
Primary hippocampal neuron culture and transfection.  
Primary neurons were prepared from hippocampi of WT or fmr1 KO C57BL/6 mice at 
postnatal day 1 to 2 and maintained in Neurobasal medium supplemented with B27 and 
Glutamine (Invitrogen). Neurons were transfected using Lipofectamine LTX 
(Invitrogen). All studies were performed in compliance with the Institutional Animal 
Care and Use Committee of University of Illinois at Urbana-Champaign. 
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Time lapse imaging.  
Primary WT or fmr1 KO hippocampal neurons were transfected and imaged within 24 
hours post-transfection. Neurons were maintained in Liebovitz’s L-15 supplemented with 
B27 at 37
o
C in a 5% CO2 live-cell incubation chamber and imaged using the 40X 
objective (NA 1.4) on a Zeiss Axiovert 200M microscope, before and after exposure to 
50μM (S)-3,5-Dihydroxyphenylglycine (DHPG, Tocris), an mGluR group I agonist, for 5 
minutes. Images were taken every 5 seconds for 25 frames.  
Immunocytochemistry.  
Primary hippocampal cells on coverslips were fixed using 4% paraformaldehyde in PBS 
and permeabilized with methanol. Neurons were incubated in primary antibody (diluted 
in 1% normal donkey serum) at 4
o
C overnight. This was followed by incubation with 
species-appropriate secondary antibodies. For surface receptor staining, neurons were 
incubated with rabbit anti-FLAG (Sigma) at room temperature for 5 minutes to allow 
labeling of N terminal FLAG tagged receptor and washed in Neurobasal medium and 
PBS. After stimulation, neurons were permeabilized and examined by regular 
immunocytochemistry procedures. 
Colocalization between FMRP and surface receptor.  
Primary hippocampal neurons were transfected with FLAG-mGluR1a, FLAG-mGluR5 or 
FLAG-2AR, which were kindly provided by Dr Stephan Ferguson, at 7 or 8 DIV. 
Cultured neurons were treated with DHPG for 5 minutes and left for the indicated 
duration after DHPG was removed. In cycloheximide treatment groups, cycloheximide 
was included in medium 30 minutes before and during experiment periods. Then neurons 
were subjected to surface receptor labeling and immunocytochemistry. Images were 
taken by Leica SP2 with a 63X (NA1.4) objective as Z-stacks with 0.3µm interval.  
Fluorescence in situ hybridization.  
Digoxigenin (DIG) labeled riboprobes were generated from plasmids with T3 or T7 RNA 
polymerase sites. A cRNA probe to CaMKII was generated from a restriction digested 
fragment corresponding to nucleotides 1014-1332 of CaMKII cDNA.  The plasmid 
pBS-CaMKII was kindly provided by Dr. Oswald Steward, UC Irvine [88]. A cRNA 
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probe to Fmr1 was generated from a restriction digested fragment corresponding to 
nucleotide 263-313 of Fmr1 cDNA. The fmr1 cDNA fragment was kindly provided by 
Dr Jim Eberwine, U Penn and inserted into pBS. CaMKII and Fmr1 probes were 
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by in vitro transcription of the cloned insert in the presence of digoxygenin-dUTP 
(Roche). To detect total poly-adenylated mRNA, a synthetic 50-mer nucleotide oligo-dT 
labeled with Cy3 at 5’ end was used. Hybridization buffer: 40% formamide, 10% dextran 
sulfate, 1x Denhardt’s solution, 4x SSC, 10mM DDT, 1mg/ml tRNA, and 1mg/ml 
denatured salmon sperm DNA. Primary neurons were fixed with 4% paraformaldehyde, 
permeabilized with methanol, and then prehybridized with hybridization buffer. Then 
neurons were incubated with probes in hybridization buffer overnight at 55
o
C for 
CaMKII probes or at 42oC for Fmr1 probes or two hours at 37oC for poly-dT oligos. 
After hybridization, cells were washed in 0.5X SSC with 50% formamide, 0.5X 
formamide and PBS. Cells were incubated with an HRP-linked DIG antibody (Roche) 
and the signal was amplified by Cy3 TSA-Plus system (PerkinElmer). 
CaMKII protein and mRNA localization in YFP spines.  
WT or fmr1 KO neurons containing Thy1-Yellow-Fluorescent-Protein (YFP) derived 
from B6.Cg-Tg(Thy1-YFPH)2Jrs/J (Jax Mice) were cultured to DIV18-21, stimulated 
with 50μM DHPG for 5 minutes, and left for the indicated period after DHPG was 
removed. After fixation, neurons were subjected to immunostaining or in situ 
hybridization as described above. Images were taken by Zeiss LSM710 with a 63X 
(NA1.4) objective as Z-stacks with a 0.3µm interval. All images in a single time-series 
group were taken under the same acquisition parameters for relative comparisons. 
GluR1 internalization assay.  
Live hippocampal neurons at DIV 21-22 were labeled for 10 min at 37
o
C with a rabbit 
antibody directed against the extracellular region of GluR1 (Calbiochem). After washing 
in conditioned medium, neurons were incubated at 37
o
C in conditioned medium 
containing 100μM DHPG for 5 min. In the cycloheximide treatment group, 60μM 
cycloheximide was present during the entire experiment. After DHPG washout, neurons 
were maintained for 15 minutes before fixation in 4% paraformaldehyde and 4% sucrose. 
Under non-permeant condition, neurons were stained with Alexa fluor555 conjugated 
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anti-rabbit for 1 hr at room temperature to visualize surface receptors. Neurons were then 
permeabilized for 1 min in 100% methanol at -20
 o
C and stained with chicken anti-GFP 
and subsequent Cy2 conjugated anti-chicken and Cy5 conjugated anti-rabbit for 1 hr to 
visualize YFP and internalized GluRs. Images were acquired by Zeiss LSM710 with a 
63X (NA1.4) objective as Z-stacks with 0.3μm interval. Cy5 fluorescence average 
intensities indicative of internalization were divided by total (Alexa fluor555+ Cy5) 
fluorescence intensities and standardized to control group (resting state in WT). 
 Imaging analysis.  
For time-lapse imaging, granules consistently motile during at least two time points were 
analyzed. Time-lapse imaging series were analyzed by ImarisTrack software (Bitplane). 
Total trafficking length of motile particles was measured and divided by time as average 
speed. The Track Displacement is the distance between the first and last position. The 
Track Length is the total length of displacements within the track. The track efficacy, 
calculated by track displacement divided by track length, is the measurement of 
unidirectional movement. Colocalization between surface receptors and FMRP was 
quantified by Mander’s coefficient of FMRP staining [89]. Mander’s coefficient of 
FMRP= sum of colocalized (Intensity of surface receptor)*(intensity of FMRP)/ sum of 
intensity of FMRP in one voxel, where (intensity of surface receptor) =1 when the voxel 
contains surface receptor staining, otherwise (intensity of surface receptor) = 0. Manders’ 
coefficient varies from 0 to 1, corresponding to non-overlapping images and 100% 
colocalization. Three dimension reconstruction and surface rendering were applied to 
YFP neuron images by using surface function of Imaris (Bitplane). Spine and dendrite 
regions of interest (ROI) were defined by YFP signals without visualizing other 
immunofluorescence channels. Intensity of CaMKII protein or mRNA was calculated as 
absolute intensity (pixel) per volume unit (voxel) and standardized by the value of resting 
state in each group. 
Statistical analysis.  
For mean comparisons, paired-t test, one-way or two-way ANOVA were performed. 
Tukey’s HSD or Dunnett was carried out as post-hoc analysis as mentioned in figure 
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legends. In all figures, data were presented as mean ± SEM, and *p<.05, **p<.01, 
***p<.001. 
The sources of the antibodies are as follows: rabbit anti-mGluR5 (Millipore), rabbit anti-
mGluR1a (Millipore), mouse anti-MAP2 (Sigma), rabbit anti-MAP2 (Millipore), chicken 
anti-MAP2 (EnCor), rabbit anti-GFP (AbCam), chicken anti-GFP (AbCam), rabbit anti-
FLAG (Sigma), mouse anti-FLAG (Sigma), mouse anti-FMRP (1C3), mouse anti-
CaMKIIα (Millipore), and mouse anti-PSD95 (AbCam). 
 
Results 
Study of mRNA distribution in WT and fmr1 KO hippocampal neurons by time-lapse 
imaging.  
To test whether FMRP regulates the dynamics of dendritic mRNA movement, we used 
time-lapse imaging to investigate mRNA movement in primary cultures of WT and fmr1 
KO hippocampal neurons. Two mRNAs, CaMKIIand Fmr1, were indirectly labeled by 
GFP-MS2 (Fig. 2.1.a), using the MS2 tethering method [90, 91], and monitored by time-
lapse imaging. CaMKII was used here because its translation is regulated by FMRP 
[55] and its dendritic trafficking was studied previously [90]. Fmr1 was chosen because 
of its high affinity association with FMRP [51]. Since FMRP may associate with Fmr1 
either through its G-quartet on the open reading frame (ORF) and/or the U-rich region on 
the 3’ untranslated region (UTR) [92, 93], we made a construct containing both the ORF 
and the 3’ UTR of Fmr1 as the RNA of interest (Fig. 2.1.a) to mimic endogenous Fmr1 
mRNA. Fig. 2.1.b shows that the ORF of the Fmr1 mRNA construct cannot be 
translated, consistent with its placement downstream of the LacZ gene stop codon. 
Although a nuclear localization signal was included in the labeling system, FMRP was 
not trapped in the nucleus (Fig. 2.1.c). Fig. 2.2.a shows that without a dendritic targeting 
signal, GFP labeled MS2 binding site (MS2bs) cannot be transported to neuronal 
dendrites. Both MS2-GFP labeled Fmr1 and CaMKII formed punctate mRNA granules 
in dendrites (Fig. 2.2.b and c). Moreover, Fmr1-containing GFP labeled granules were 
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co-localized with Fmr1 RNA signals as shown by fluorescence in situ hybridization (Fig. 
2.2.d), confirming that GFP labeled granules contained Fmr1 mRNA. 
Next, to compare the dynamic movement of mRNA in WT and fmr1 KO hippocampal 
neurons, either CaMKII or Fmr1 labeling constructs were transfected into WT and fmr1 
KO neurons. mRNA granules in single dendrites were imaged 5 seconds per frame for 25 
frames (2 minutes in total) before and after stimulation by the group I mGluR agonist, 
DHPG (Fig. 2.3.a). We found that the majority of granules was stationary, as reported 
before [90]. Therefore, we measured the trafficking pattern of motile granules, 
representing their engagement with motor proteins, in at least two time-series. The 
movement dynamics of CaMKII or fmr1 granules were measured as average speed and 
as unidirectional movement efficacy, which is a measurement of the degree to which the 
granule travels in a single direction. In WT neurons, the average speed of Fmr1 granules 
(Fig. 2.3.b Left) was decreased between 0 and 40 minutes after DHPG stimulation 
compared to the speed before stimulation. However, in fmr1 KO neurons, average speed 
did not change significantly after stimulation. The average speed of CaMKII granules 
showed similar changes (Fig. 2.3.b Right); in WT, but not KO neurons, CaMKII mRNA 
significantly slowed during 0-40 minutes post-stimulation. This suggests FMRP may act 
to decelerate mRNA movement in the early phase (0-40 min) after group I mGluR 
treatment. The average speed of CaMKII (82.96 nm/sec) was comparable to a previous 
report [90]. Interestingly, the average speed at baseline (pre-stimulation) was 
significantly lower in fmr1 KO neurons compared with WT neurons.  
The directionality of Fmr1 granules in WT neurons was significantly higher during 40 
and 60 minutes after DHPG treatment (Fig. 2.3.c Left). There was a similar trend (not 
significant) for CaMKII granules in WT neurons compared to fmr1 KO neurons (Fig. 
2.3.c Right). The apparent increase in unidirectional Fmr1 mRNA movement might 
indicate a regulatory interaction between FMRP and motor proteins and mRNA in 
response to stimulation [60, 61, 65]. It is important to note that total granule number and 
the percentage of motile granules were not significantly different between WT and fmr1 
KO neurons. However, the brightness of Fmr1 granules in WT was significantly higher 
after DHPG treatment, but not in fmr1 KO neurons (Fig. 2.3.d). This suggests that 
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mRNA, previously below detection and measurement levels, may be incorporated into 
granule structures by DHPG stimulation in WT, but not KO neurons. 
 
FMRP was translated near group I mGluRs. 
Next, we used double label immunofluorescence to examine translation of FMRP in 
regions near group I mGluR. We chose the cellular micro-domain of group I mGluR 
because it is linked to signal pathways: mGluR1a-mediated ERK phosphorylation is 
enriched after stimulation in the membrane fraction [94] and the ERK pathway is crucial 
for group I mGluR dependent plasticity [95]. N-terminal FLAG tagged mGlu1a and 
mGluR5, two members of the group I mGluR family, were individually expressed in 
primary hippocampal neurons to label surface receptor regions. Surface mGluR1a and 
mGluR5 were recognized by anti-FLAG under non-permeabilized conditions (Fig. 2.5.a). 
Colocalization between endogenous FMRP and the surface receptor was measured at 
different time points after DHPG treatment (Fig. 2.4.a). Our results show that 
colocalization between FMRP and surface mGluR5 was significantly elevated at 20 
minutes after DHPG treatment (Fig. 2.4.b). While treated with a protein synthesis 
blocker, cycloheximide (CHX), there was not a greater colocalization (Fig. 2.4.c). This 
suggests that FMRP was newly synthesized in regions close to surface mGluR5 in 
response to group I mGluR stimulation, although some FMRP transport may still occur. 
There was only a slight increase in colocalization between FMRP and surface mGluR1a, 
and this change did not occur until 40 minutes (Fig. 2.4.d). The difference between 
mGluR5 and mGluR1a may have been caused by different representation of surface 
receptor constructs since surface mGluR5 staining showed better representation of 
endogenous mGluR5 (Fig. 2.5.b). Lastly, surface 2 adrenergic receptor (2AR), another 
G-protein coupled receptor, was used as a negative control since it cannot be stimulated 
by group I mGluR agonist. DHPG stimulation caused no change in colocalization 
between FMRP and 2AR (Fig. 2.4.e). This suggests translation of FMRP could be 
enriched temporally within active receptor regions. 
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FMRP targets translation of CaMKII to dendritic spines.  
To investigate whether mRNA and newly translated protein are localized at excitatory 
synaptic sites in the presence of FMRP we looked at levels of CaMKII mRNA and 
protein in dendritic spines at different time points after group I mGluR stimulation. We 
examined the intensity of CaMKII protein at spines and adjacent area of dendrites in 
WT and fmr1 KO neurons that endogenously expressed YFP (Fig. 2.6.a and b). Based on 
our previous results we defined five time points from the washout after 5 minutes of 
treatment with DHPG. At 10 minutes in WT spines the level of CaMKII peaks and is 
significantly higher than at the pre-DHPG resting state. In KO spines, on the other hand, 
there is a delayed, non-significant increase above baseline at 20 minutes after DHPG 
treatment (Fig. 2.6.c). Dendrites showed the same temporal pattern of protein translation 
as spines, although the changes were smaller, and non-significant (Fig. 2.6.d).  
Next, we compared the levels of enrichment of CaMKII at individual spines with the 
adjacent dendrite after DHPG stimulation in WT and fmr1 KO neurons (Fig. 2.6.e). The 
ratios were standardized to the level at resting state. In WT neurons, the spine to dendrite 
ratio of CaMKII was enriched at 20 minutes after DHPG removal compared to pre-
stimulation, whereas the KO showed no significant change in ratio from baseline at any 
time point following stimulation. Furthermore, compared with KO, WT neurons showed 
higher spine to dendrite enrichment of CaMKII at 0, 20 and 40 minutes following 
stimulation.  
Finally, we asked if the elevated level of CaMKII
synthesis after group I mGluR stimulation. After neurons were treated with 
cycloheximide, the increase in CaMKII levels seen in WT spines at 10 minutes after 
DHPG treatment was no longer apparent (Fig. 2.6.f). Similarly, the spine to dendrite 
enrichment ratio shows an increased trend in untreated neurons that is not present after 
cycloheximide treatment, such that at 20 minutes there is a significant difference between 
the enrichment ratios in treated vs. untreated neurons (Fig. 2.6.h). These findings suggest 
that in the presence of FMRP, CaMKII is translated and enriched at individual spines by 
20 minutes after the cessation of stimulation. 
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Local targeting of CaMKII mRNA to WT spines. 
To test targeting of CaMKII mRNA at dendrites or spines after group I mGluR 
stimulation we examined CaMKII mRNA puncta localization in YFP-labeled WT and 
fmr1 KO neurons by fluorescence in situ hybridization (Fig. 2.7.a and b). The total 
number and average intensity of RNA puncta (larger than 0.3μm), as well as the ratio of 
RNA puncta localized in spines to total RNA puncta was calculated for each 50μm 
segment of dendrite. The total number of RNA puncta within 50μm of dendrite did not 
change over time after stimulation in either WT or fmr1 KO dendrites (Fig. 2.7.c). The 
intensity of total RNA puncta was rapidly and significantly elevated in WT, but not in 
fmr1 KO neurons, immediately after DHPG washout (0 min), compared with pre-
stimulation intensity (Fig. 2.7.d). More interestingly, the fraction of RNA puncta at WT 
spines compared to total dendritic puncta was significantly higher at 0 minutes compared 
to baseline (Fig. 2.7.e). As a control for mRNA binding specificity of FMRP, we further 
showed that the level of polyA mRNA does not change over time after stimulation (Fig. 
2.8). These data suggest that in response to group I mGluR stimulation mRNA 
granules/mRNPs can be delivered to excitatory synapses for a period following 
stimulation, and that this delivery requires FMRP. 
Localization of GluR1 internalization.  
Previous research has shown that dysregulated GluR1 internalization in fmr1 KO neurons 
is associated with the lack of control of translation machinery [58]. To understand if 
internalization of GluR1 could be spatially localized, we further investigated the level of 
GluR1 internalization by staining of surface and internal GluR1 receptors at WT and KO 
dendrites and spines after group I mGluR stimulation. The ratio of internal staining 
versus total GluR1 staining was analyzed in WT and fmr1 KO neurons, at 15 minutes 
after DHPG removal (Fig. 2.9.a). The level of GluR1 internalization was significantly 
elevated in WT spines after DHPG stimulation, but was not elevated in KO spines (Fig. 
2.9.b). Furthermore, the stimulation-induced internalization in WT spines was blocked by 
the protein-synthesis inhibitor cycloheximide. In contrast, GluR1 internalization was 
elevated in the dendrites of non-stimulated KO neurons compared with WT dendrites, 
and stimulation with DHPG did not increase the level of dendritic internalization. KO 
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dendrites treated with cycloheximide alone also showed enhanced internalization 
compared with untreated WT dendrites, although dendrites treated with cycloheximide 
and DHPG together did not (Fig. 2.9.c). We also compared the enrichment of internalized 
GluR1 in spines with the adjacent dendritic area (Fig. 2.9.d). WT stimulated by DHPG 
showed a non-significant trend towards more internalization than did KO under the same 
conditions. Together, these data suggest that GluR1 internalization could fail to be 
localized in fmr1 KO neurons as well as failing to respond to stimulation. 
 
Discussion 
We have presented evidence that FMRP can target mRNAs toward specialized locations 
for de novo protein synthesis and subsequent translation-dependent plasticity events. 
First, using time-lapse imaging, we showed that Fmr1 and CaMKII RNA particles 
decelerated their motion during 0-40 minutes after group I mGluR stimulation and 
returned to their basal level of movement during a later stage. We hypothesized that 
during this early time period RNAs associated with FMRP might be targeted to 
specialized microenvironments for protein synthesis necessary for subsequent GluR1 
internalization and other plasticity-related changes. Second, we showed that translation of 
FMRP occurs locally adjacent to mGluR5 rich regions. Third, our experiments using 
YFP-labeled spines revealed that endogenous CaMKII mRNAs and protein synthesis of 
CaMKII are enriched at spines compared with neighboring dendritic regions only in the 
presence of FMRP. Lastly, the internalization of GluR1 occurs at spines in WT neurons, 
but in dendrites of KO neurons after stimulation. Furthermore, internalization in KO 
dendrites appears to be constitutively higher in fmr1 KO dendrites compared with WT 
dendrites. These data strongly corroborate our hypothesis whereby FMRP enhances RNA 
targeting to specialized regions for local translation in response to neuronal stimulation. 
Using time lapse imaging, we observed that during the period 0-40 minutes after 
neurotransmitter treatment, mRNA granules exhibited slower motion than before 
stimulation. We speculated that this stage may represent the docking of mRNA granules 
based on evidence from the literature. First, it has been shown that the “hotspots” of 
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dendritic translation are spatially stable after stimulation and co-localized with ribosomes 
[31, 32]. Second, the selective association of FMRP between microtubules or 
polyribosome may provide translation initiation control [62]. Third, it has been 
demonstrated that FMRP-mRNP complexes relocate into dendritic spines after 
stimulation [48]. Lastly, Myosin V associates with another RNA binding protein, TLS, 
to localize mRNA into dendritic spines [47, 96, 97]. We have now shown quantitative 
data comparing the temporal and spatial distribution of CaMKII mRNA, CaMKII 
protein and GluR1 internalization in WT and fmr1 KO neurons upon group I mGluR 
stimulation.  Our data suggest that while dendritic translation events are spatially static, 
spines could be the targets for mRNA docking and protein synthesis in response to 
neuronal stimulation. 
FMRP can also facilitate directional Fmr1 mRNA granules/mRNPs movement (Fig. 
2.3.c) at 40-60 minutes after group I mGluR stimulation. This agrees with a previous 
finding that in dfmr mutant neurons CG9293 mRNA exhibits less directional movement 
[98]. The increased transport efficacy at 40-60 minutes suggests the heightened 
unidirectional movement in the presence of FMRP, which may be associating with motor 
proteins. mRNA granules/mRNPs could be carried by FMRP into the dendritic 
compartment from the soma; or mRNAs may be delivered toward nearby stress granules 
and/or P-bodies for storage or mRNA decay [99-102]. Alternatively, these translation-
primed mRNAs may be transported to active synaptic regions and be deposited there for 
the next translation event to induce plasticity, including morphological and physiological 
changes in dendritic spines that may strengthen or weaken the synapse as necessary 
[103]. Further investigation will be required to elucidate the purpose and the mechanism 
of directional dendritic mRNA transport in response to neuronal stimulation. 
In an earlier study, Dictenberg et al [65] compared CaMKII labeling granules 
movement in WT and fmr1 KO dendrites. Under conditions of chronic (15 minutes) 
DHPG treatment, they found faster movement of granules in WT than KO. We also 
observed faster movement in WT dendrites under basal conditions. We then compared 
this basal movement to movement after acute (5 minutes) DHPG stimulation to imitate 
more closely a natural stimulation event. In this case, both CaMKII and Fmr1 bearing 
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granules exhibited an initial decrease in movement, recovering to basal level after 40 
minutes post-stimulation. In addition, we observed that the large motile particles become 
brighter after stimulation (Fig. 2.3.d and 2.7.d); we attribute this to aggregation with 
smaller sub-threshold particles. This would be in agreement with studies of mRNA 
transport dynamics, based on FRAP (fluorescence recovery after photobleaching) [63, 
104], that showed rapid recovery of average fluorescence intensity in photo-bleached 
dendritic segment after stimulation. 
FMRP mediated translation-dependent synaptic plasticity may be regulated at several 
levels. First, dendritic transport and synaptic docking of mRNA could regulate the 
availability of specific mRNAs for local protein synthesis. FMRP could regulate dendritic 
transport of specific mRNAs after neuronal stimulation [63, 65]. We have shown that 
FMRP can facilitate the localization of CaMKIImRNA (one of several mRNAs 
associated with FMRP) at dendritic spines for subsequent translation, lending support to 
the role of FMRP in regulatory synaptic delivery of specific mRNA. Second, the 
restriction of protein distribution by proteasome degradation could be important for 
synaptic function as well. mGluR-LTD induces a transient, translation-dependent 
increase in FMRP that is rapidly degraded by the ubiquitin-proteasome pathway [55]. 
Lastly, the involvement of miRNAs associated with FMRP in synaptic protein expression 
is also emerging [105, 106]. FMRP is critically involved in several levels of regulation of 
protein synthesis for synaptic plasticity and the current work suggests a dynamic role of 
FMRP in transport, spine localization, rapid translational control, and receptor 
internalization. 
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Figures 
Figure 2.1 MS2 labeling strategy and its controls. 
(a) Dual constructs for GFP labeling of mRNA were shown in Rook MS et al, 2000. 
Briefly, CaMKII 3’UTR was linked with eight copies of MS2 binding site RNA 
(MS2bs-CaMKII), which has strong affinity to MS2 protein. Fmr1 ORF-3’UTR was 
subcloned to replace CaMKII (MS2bs-fmr1) to label fmr1 mRNA. MS2 binding site 
RNA alone (MS2bs) was used as a negative control. GFP tagged MS2 with nuclear 
localization signal (GFP-MS2-nls) labeled CaMKII or fmr1 mRNA via MS2-MS2bs 
interaction in live neurons.  
 
a. 
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Figure 2.1 MS2 labeling strategy and its controls. (cont.) 
(b) WT or fmr1 KO neurons were transfected with GFP-MS2-nls and MS2bs-fmr1. GFP 
labeled fmr1 form puncta (green) in dendrite. FMRP (red) appeared only in WT neurons 
by immunostaining, demonstrating that FMRP cannot be translated from MS2bs-fmr1 
construct. Scale bar, 10μm.  
 
b. 
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Figure 2.1 MS2 labeling strategy and its controls. (cont.) 
(c) There is similar FMRP (red) distribution in mock-transfected or dual fmr1-labeling 
constructs transfected WT neurons; therefore nuclear localization signal (nls) on GFP-
MS2-nls does not trap FMRP in the nucleus. 
 
c. 
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Figure 2.2 Labeling of CaMKII and Fmr1 mRNA in primary hippocampal 
neurons. 
(a) A neuron transfected with GFP-MS2-nls and MS2bs showed that GFP signals stay in 
soma. (b,c) The neuron transfected with GFP-MS2-nls and MS2bs-CaMKII or MS2bs-
fmr1 showed that mRNA puncta distribute in dendrites. Higher magnification of the 
boxed image showed GFP-labeled granules in dendrites.  
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Figure 2.2 Labeling of CaMKII and Fmr1 mRNA in primary hippocampal 
neurons. (cont.) 
(d) Fmr1 containing GFP-labeled granules (green) in dendrites colocalized with Fmr1 
mRNA detected by fluorescence in situ hybridization (FISH, red). Scale bar, 10μm. 
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Figure 2.3 CaMKII and Fmr1 mRNA dynamic motions in WT and fmr1 KO 
hippocampal neurons. 
(a) Representation of Fmr1 mRNA movement in WT and fmr1 KO neurons by time lapse 
imaging. Kymograph (upper) shows granule motion in the boxed region of a WT or KO 
neuron transfected with GFP-MS2-nls and MS2bs-Fmr1. The time point of image taken 
is labeled next to each kymograph, which represents a two-minute series of images at 
five-second intervals (25 frames in total). Scale bar, 20μm. Track length (lower) of each 
quantified Fmr1 granule (arrowhead in kymograph) was represented. Track Length is the 
total length of displacements within the track.  
a. 
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Figure 2.3 CaMKII and Fmr1 mRNA dynamic motions in WT and fmr1 KO 
hippocampal neurons. (cont.) 
(b) Average speed of GFP labeled Fmr1 or CaMKII mRNA calculated for WT or fmr1 
KO neurons, shows that particle movement was retarded in WT from 0-40 min after 
stimulation. (c) Directionality of GFP labeled Fmr1 or CaMKII in WT or fmr1 KO 
neurons was calculated, showing increased unidirectional movement of Fmr1 mRNA in 
WT neurons. Bar graph represents data from 3 experiments, total of at least 20 mRNA 
particles in each group. Experiments and definition of average speed and transport 
efficacy were as described in methods. Statistical analysis by two-way ANOVA with 
Tukey HSD post test. Error bars denote SEM. 
b. 
 
c. 
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Figure 2.3 CaMKII and Fmr1 mRNA dynamic motions in WT and fmr1 KO 
hippocampal neurons. (cont.) 
(d) The intensity of GFP labeled Fmr1 mRNA in time lapse imaging was measured 
before or after DHPG treatment. The pair-wise comparison of granule intensity was only 
applied to the time series with exact imaging parameters before and after stimulation. 
Statistical analysis by two-tailed t-test. Error Bars denote SEM. 
 
d. 
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Figure 2.4 Colocalization between surface group I mGluRs and FMRP after DHPG 
treatment. 
(a) Representative deconvolved image (Z projection) detected surface mGluR5 (red) and 
endogenous FMRP (green). Higher magnification of the boxed image shows that more 
FMRP colocalized with surface mGluR5 at 20 minutes after DHPG (yellow arrow), but 
not in the presence of CHX (cycloheximide). Scale bar, 20m.  
a. 
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Figure 2.4 Colocalization between surface group I mGluRs and FMRP after DHPG 
treatment. (cont.) 
(b-e) The increased colocalization between FMRP and surface mGluR5 at 20 min was 
measured as Mander’s coefficient. The time points indicate the time post washout after 5-
min DHPG incubation. Data were analyzed from at least 15 dendrites in each group, 3 
independent experiments. Statistical analysis by one-way ANOVA with Dunnett’s post 
test. Error bars denote SEM. 
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Figure 2.5 Controls for surface staining of FLAG tagged receptor and relative 
distribution of surface FLAG-receptor and endogenous receptors. 
(a) Immunofluorescence (IF) of anti-FLAG (green) and anti-mGluR1a or anti-mGluR5 
(red), which recognizes intracellular epitope of the receptor, was performed under non-
permeant condition in FLAG-mGluR1a or FLAG-mGluR5 transfected hippocampal 
neurons. Only FLAG on cell surface can be stained but not the intracellular portion of 
endogenous mGluR1a or mGluR5. This shows that only the surface portion of receptors 
was labeled by this method.  
 
a. 
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Figure 2.5 Controls for surface staining of FLAG tagged receptor and relative 
distribution of surface FLAG-receptor and endogenous receptors. (cont.) 
(b) IF of surface group I mGluR was compared to the staining pattern of endogenous 
receptors. In b1, almost all surface staining of mGluR5 (green) corresponds with the 
staining of endogenous mGluR5 (red). However, in b2, the staining of surface mGluR1a 
(green) does not fully co-localize with endogenous mGluR1a (red). The relative 
distribution of surface mGluR5 versus endogenous mGluR1a (b3) and surface mGluR1a 
versus endogenous mGluR5 (b4), as negative controls, showed the degree of overlapping 
of two different receptors. 
 
 
 
  
39 
 
Figure 2.6 The differential distribution of CaMKII protein in neuronal spines and 
dendrites in response to group I mGluR stimulation. Cycloheximide blocks local 
translation of CaMKII in spines of WT neurons. 
(a) Yellow fluorescence protein (YFP) expressing hippocampal neurons (green) were 
used to outline neuronal dendrites and spines. A higher magnification of the boxed region 
shows that spine (yellow) and neighboring dendrite (white) regions could be selected 
based on YFP staining threshold. Scale bar, 10μm. (b) Representative figures of 
CaMKII immunostaining (red) in WT or fmr1 KO YFP hippocampal neurons showed 
relative CaMKII distribution in spines or dendrites in response to group I mGluR 
stimulation (DHPG).  
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Figure 2.6 The differential distribution of CaMKII protein in neuronal spines and 
dendrites in response to group I mGluR stimulation. Cycloheximide blocks local 
translation of CaMKII in spines of WT neurons. (cont.) 
(c, d) The average intensity of CaMKII protein in WT or fmr1 KO YFP spines (c) or 
adjacent dendrites (d) was measured and compared to CaMKII level before stimulation. 
(e) Enrichment of CaMKII mRNA in spine relative to adjacent dendrite was calculated 
and normalized to the level before DHPG treatment. (f, g) In the presence or absence of 
60M cycloheximide, a protein synthesis blocker, throughout the experiment, the level of 
CaMKII in spines (f) or neighboring dendrites (g) of WT neurons was measured. (h) In 
the presence or absence of 60M cycloheximide, the level of CaMKII in WT spines 
versus dendrites was calculated as the level of CaMKII in one spine divided by the level 
in the neighboring dendrite. Data were analyzed from at least 18 dendrites in each group, 
three independent experiments. Statistical analysis by two-way ANOVA with Tukey-
HSD post test. Error bars denote SEM. 
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Figure 2.7 The differential distribution of endogenous CaMKII
neuronal spines and dendrites of WT or fmr1 KO neurons in response to group I 
mGluR stimulation. 
(a) FISH detected CaMKII mRNA (red) in dendrite of YFP hippocampal neurons (left). 
Hybridization with a sense probe showed no detectable labeling in dendrite (right). Scale 
bar, 10μm. (b) Two magnified figures of spines (arrows in A) showed that CaMKII 
mRNA could be localized in spine head, adjacent dendrite region (left), or spine base 
(right). 
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Figure 2.7 The differential distribution of endogenous CaMKII
neuronal spines and dendrites of WT or fmr1 KO neurons in response to group I 
mGluR stimulation. (cont.) 
(c) The number of CaMKII mRNA particles in 50μm dendrite segments was calculated 
in WT and fmr1 KO neurons before or at different time points after 5 min DHPG 
treatment. (d) The average intensity of CaMKII mRNA was measured in each 50μm 
dendrite segment. The level of average intensity was compared to the level before DHPG 
stimulation in WT or fmr1 KO neurons.  
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Figure 2.7 The differential distribution of endogenous CaMKII
neuronal spines and dendrites of WT or fmr1 KO neurons in response to group I 
mGluR stimulation. (cont.) 
(e) The ratio of the number of CaMKII mRNA localized in spines versus total number 
of CaMKII in each 50μm dendrite segment was calculated, showing a peak ratio 
immediately after DHPG stimulation in WT but not KO. Data were analyzed from at 
least 20 dendrites in each group, three independent experiments. In c and d, data were 
analyzed by two-way ANOVA with Tukey-HSD post-test. In e, the value of ratio was 
transformed to meet normality requirement and then analyzed by two-way ANOVA with 
Tukey-HSD. Error bars denote SEM. 
 
 
  
44 
 
Figure 2.8 The distribution of polyA mRNA in neuronal dendrites or spines.  
(a) Representative figures showing fluorescence in situ hybridization of polyA mRNA in 
YFP neurons (upper). The negative control, a probe to recognize polyT, did not show 
clear staining in neuronal dendrites (lower). (b, c) The intensity of polyA FISH was 
measured in spines (b) or adjacent dendrites (c) of YFP neurons. Statistical analysis by 
two-way ANOVA. Error Bars denote SEM. 
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Figure 2.9 The level of GluR1 internalization in neuronal spines or dendrites 15 
minutes after Group I mGluR stimulation. 
(a) Representative images showing surface or internalized GluR1 in control or DHPG 
treated WT or fmr1 KO neurons. Scale bar, 2μm.  
a. 
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Figure 2.9 The level of GluR1 internalization in neuronal spines or dendrites 15 
minutes after Group I mGluR stimulation. (cont.) 
(b, c) The level of GluR1 internalization was measured in spine or dendrite regions 
defined by YFP. The internalization levels were compared to the level in WT control 
group. While WT neurons showed more spine internalization, fmr1 KO neurons exhibited 
more dendritic internalization. (d) The level of GluR1 internalization per spine was 
compared to the level in the neighboring dendrite. Data were analyzed from at least 15 
dendrites in each group, three independent experiments. Statistical analysis by two-way 
ANOVA and Dunnett’s post test. Error Bars represent SEM. 
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Chapter 3. 
The role of FMRP isoforms in synaptic mRNA docking 
 
Abstract 
To better understand the function of individual FMRP isoforms and the potential for gene 
therapy in Fragile X Syndrome, we investigated their reactivity in synaptic mRNA 
targeting. We studied specific FMRP isoforms (iso1, iso2, iso7 and iso8) that differ with 
regard to the hydrophobic loop extended from KH2 domain and by serine 499 
phosphorylation modification. By using time-lapse imaging, we found that EGFP labeled 
iso1 and iso7 granules can significantly decelerate following 5 minutes DHPG treatment 
in wild type neurons but not in fmr1 KO neurons. However, reinstating iso1, iso7 or iso2 
cannot restore CaMKII mRNA targeting to fmr1 KO spines after DHPG treatment as 
observed in wild type spines. The data suggest that a single FMRP isoform was not 
sufficient to restore the function of synaptic mRNA delivery, but requires the presence of 
multiple isoforms. 
 
Introduction 
Fragile X syndrome (FXS) is the most common form of inherited mental retardation and 
is caused by the loss of function of the FMR1 gene, which encodes fragile X mental 
retardation protein (FMRP) [1]. FXS affects 1 in 4000 males and 1 in 6000 females on 
average and is characterized by hyperactivity, attention deficits, autistic-like behaviors, 
and seizures [2]. Dendritic spine morphology in the cerebral cortex of FXS patients and 
in the fmr1 KO mouse model shows more immature long thin spines than mature stubby, 
mushroom-shaped spines [8]. Furthermore, group I-mGluR dependent long term 
depression (LTD) in the hippocampus is exaggerated in the fmr1 KO model [10]. These 
findings suggest that FMRP functions in synaptic development and plasticity. 
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Alternative splicing variants of FMRP are synthesized in response to group I mGluR 
stimulation [12] and environmental stimuli [107]. However, there are limited studies that 
differentiate diverse properties of FMRP splicing variants [84-86]. To better optimize the 
possibility of gene therapy in FXS [108], we investigated the function of individual 
FMRP splicing isoforms. The FMR1 gene contains 17 exons and 4 possible alternative 
splicing sites [80, 82]. Alternative splicing affects the presence of exon12 and exon14, 
and the selective usage of splicing acceptors on exon15 and exon17 (Fig. 3.1.a). Because 
an intact KH2 domain and phosphorylation modification of serine 499 of FMRP are 
critical to maintain synapse number and modulate the translation process [41, 109], we 
are particularly interested in contributions to synaptic function that may be encoded by 
exon12 and exon15, which correspond to a hydrophobic extension loop of KH2 domain 
and a fragment containing serine 499, respectively. Interestingly, the absence of exon12 
can enhance the association between FMRP and an RNA segment called the “kissing 
complex” [84, 110], even though there is not as yet an identified FMRP-associated 
mRNA containing the kissing complex. Therefore, we characterized the properties of 
dynamic motions and synaptic targeting of CaMKIImRNA of FMRP iso1, iso2, iso7 
and iso8, displaying differential splicing of exon12 and/or the phosphorylation site in 
exon15 (Fig. 3.1.b).  
Fmr1 exon12 and exon15 mRNA splicing variants showed disparate RNA abundance. 
Approximately 80% of Fmr1 mRNA in mouse brain lack exon12 due to alternative 
splicing [80]. Throughout development, Fmr1 lacking exon12 is more abundant in brain 
tissues. However, in mouse cortex synaptosomes, Fmr1 containing exon12 is more 
enriched than those lacking exon12 [84], suggesting that Fmr1 containing exon12 could 
be enriched in synapses. Among three splicing acceptors (a, b and c) on exon15, exon15a 
is used most frequently in both adult and embryonic brain tissue [84]. So far, it is still 
technically problematic to distinguish FMRP isoforms at protein level, including using 
2D-gel [111]. Therefore, the relative content of each FMRP isoform is still unclear. 
In this study, we investigated dynamic movement of single FMRP isoforms, and isoform 
regulation of synaptic docking of CaMKII mRNA in neuronal dendrites. To better 
understand the regulatory role of a KH2 extension loop (exon12) and serine499 
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phosphorylation (exon15), we characterized iso1, iso2, iso7 and iso8, on which exon12 
and exon15 are alternatively spliced. 
 
Materials and Methods 
DNA constructs.  
EGFP-Fmr1 isoform plasmid was generated by inserting Fmr1 isoform cDNA into a 
pEGFP-C1 (Clontech) vector using EcoRI and XhoI. pIRES-EGFP-mRFP-Fmr1 isoform 
was constructed by sequential insertion of the Fmr1 3’ UTR PCR fragment and mRFP-
Fmr1 isoform cDNA into pIRES-EGFP (Clontech) vector. All plasmids were sequenced 
to verify their composition. 
Primary hippocampal neuron culture and transfection.  
Primary neurons were prepared from hippocampi of WT or fmr1 KO C57BL/6 mice at 
postnatal day 1 to 2 and maintained in Neurobasal medium supplemented with B27 and 
Glutamax (Invitrogen). Neurons were transfected using Lipofectamine LTX (Invitrogen) 
at postnatal day 7 and maintained to the age indicated in each experiment. All studies 
were performed in compliance with the Institutional Animal Care and Use Committee of 
University of Illinois at Urbana-Champaign. 
Time lapse imaging.  
Primary WT or fmr1 KO hippocampal neurons were transfected and imaged within 24 
hours post-transfection. Neurons were maintained in Liebovitz’s L-15 (Invitrogen) 
supplemented with B27 (Invitrogen) at 37
o
C in a 5% CO2 live-cell incubation chamber 
and imaged using the 40X objective (NA 1.4) on a Zeiss Axiovert 200M microscope, 
before and after exposure to 50μM (S)-3,5-Dihydroxyphenylglycine (DHPG, Tocris), an 
mGluR group I agonist, for 5 minutes. Images were taken every 5 seconds for 25 frames.  
Imaging analysis.  
For time-lapse imaging, granules consistently motile during at least two time points were 
analyzed. Time-lapse imaging series were analyzed by ImarisTrack software (Bitplane). 
Total trafficking length of motile particles was measured and divided by time as average 
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speed. The Track Displacement is the distance between the first and last position. The 
Track Length is the total length of displacements within the track. The track efficacy, 
calculated by track displacement divided by track length, is the measurement of 
unidirectional movement. Fluorescence recovery after photobleaching (FRAP) images 
were taken every 10 seconds for 5 minutes while three images were taken before 
photobleaching on a Zeiss 710 confocal microscopy. FRAP data were presented by 
percentage of recovery of the GFP intensity comparing to the intensity level before 
photobleaching as 100% and after photobleaching as 0%. The mobile fraction is 
determined by comparing the fluorescence intensity in the bleaching region after 
equilibrium is reached (I) with the intensities before (Ii) and immediately after (I0) 
bleaching. The mobile fraction (I) is defined as: I= (I–I0)/ (Ii-I0) [112]. All imaging and 
bleaching parameters were kept the same during three replicates. 
Fluorescence in situ hybridization.  
Digoxigenin (DIG) labeled riboprobes were generated from plasmids with T3 or T7 RNA 
polymerase sites. Primary neurons were fixed with 4% paraformaldehyde, permeabilized 
with methanol, and then prehybridized with hybridization buffer. Then neurons were 
incubated with probes in hybridization buffer overnight at 55
o
C for CaMKII probes, 
described previously [113]. After hybridization, cells were washed serially in 0.5X SSC 
with 50% formamide, 0.5X SSC and PBS. Neurons were incubated in primary antibody 
(chicken anti-GFP, AbCam) at 4
o
C overnight and Cy2-anti-chicken (Jackson Immuno 
Research). Cells were then incubated with an HRP-linked DIG antibody (Roche) and the 
signal was amplified by Cy5 TSA-Plus system (PerkinElmer). Images were taken by 
Zeiss LSM710 with a 63X (NA1.4) objective as Z-stacks with a 0.3µm interval. All 
images in a single group were taken under the same acquisition parameters for relative 
comparisons. 
Statistical analysis.  
For mean comparisons, independent t-test, one-way or two-way ANOVA was performed. 
Tukey’s HSD was carried out as post-hoc analysis as mentioned in figure legends. In all 
figures, data were presented as mean ± SEM, and *p<.05, **p<.01, ***p<.001. 
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Results 
EGFP labeled iso1 and iso7 granules decelerated in wild type neurons following 
stimulation. 
To investigate the dynamic motion of FMRP isoforms affected by either the hydrophobic 
loop extended from KH2 domain or the phosphorylation site (serine 499) on exon15, we 
examined the speed of EGFP tagged FMRP iso1, iso2, iso7 and iso8 following DHPG 
treatment (Fig. 3.2). To elucidate if a single FMRP isoform is sufficient we compare its 
dynamic motion when the single isoform was expressed in fmr1 KO neurons (with no 
FMRP) with the motion in wild type neurons (with a full array of FMRP isoforms). 
Transfected neurons were imaged by time-lapse microscopy within 24 hours after 
transfection to keep exogenously expressed FMRP at a low level.  
Iso1, the full length FMRP, exhibited retarded motion at 0-20 minutes after DHPG 
treatment in only wild type neurons (Fig. 3.2.a), as previously observed [113]. The speed 
of iso1 in wild type neurons was significantly reduced from 0.128±0.018m/sec before 
stimulation to 0.061±0.006m/sec at 0-20 minutes after DHPG removal (p<0.05, Tukey 
post test). In fmr1 KO neurons, there was no retardation of movement. This result 
suggested that the change mobility of iso1 granules requires the presence of other 
isoforms.  
Iso2, which contains a hydrophobic loop from the KH2 domain but not the 
phosphorylation site of serine 499, actually exhibited faster movement in the absence of 
other isoforms (0.180±0.034m/sec in fmr1 KO versus 0.091±0.016m/sec in wild type 
neurons, p<0.05, Fig. 3.2.b), especially at 0-20 minutes after DHPG removal. This 
suggests that FMRP isoforms other than iso2 might act as a brake to decelerate RNA 
granules upon group I mGluR stimulation.  
Iso7, which contains the phosphorylation site of serine 499 but not a hydrophobic loop 
from the KH2 domain, slowed down after stimulation but the deceleration is statistically 
significant only in wild type neurons (0.132±0.014m/sec before stimulation comparing 
to 0.082±0.011m/sec at 0-20 min (p<0.05), 0.074±0.006m/sec at 20-40 min (p<0.01), 
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and 0.074±0.012m/sec at 40-60 min (p<0.01) after DHPG removal, Fig. 3.2.c). The 
response to stimulation was similar to iso1; only in the presence of other isoforms was 
iso7 able to effectively decelerate. 
Iso8, which contains neither a hydrophobic loop of the KH2 domain nor the 
phosphorylation site serine 499, did not significantly alter its speed over one hour time 
course after DHPG removal (Fig. 3.2.d) in both wild type and fmr1 KO neurons. 
Although there was a trend towards slower motion at 20-40 minutes after DHPG 
removal, especially in wild type neurons, it is not statistically significant.  
The data suggest that iso1 and iso7 may be the main contributors to mRNA granule 
deceleration in response to group I mGluR stimulation. More importantly, they cannot 
perform the function effectively without the presence of other isoforms. 
 
Spine targeting of CaMKIImRNA in fmr1 KO could not be restored by introducing a 
single FMRP isoform. 
We next investigated if a single FMRP isoform is able to localize CaMKII mRNA to 
fmr1 KO spines as shown previously [113]. We designed constructs carrying mRFP alone 
or single mRFP tagged isoforms together with IRES-EGFP. By introducing the tandem 
construct at DIV7, spine morphology can be labeled by EGFP and mRFP-isoform will 
conduct its functions in the same neuron. At DIV19 to 21, neurons were stimulated by 50 
m DHPG for 5 minutes and endogenous CaMKII was labeled by fluorescence in situ 
hybridization. Total number of CaMKII puncta (> 0.3 m) within every 50 m 
dendritic segment did not change over one hour after group I mGluR stimulation (Fig. 
3.3).  
The fraction of CaMKII mRNA in spines of wild type neurons transfected with pIRES-
EGFP-mRFP was highest at 0 minutes after stimulation and decreased for the following 
60 minutes (0.059±0.013 before stimulation versus 0.148±0.027 at 0 minute after 
stimulation in WT neuron, p<0.05, Fig 3.4.a), but not in transfected fmr1 KO neurons, 
consistent with our previous results [113].  
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In WT neurons transfected with pIRES-EGFP-mRFP-iso1 (Fig. 3.4.b), there was still a 
significant elevation of CaMKII mRNA fraction localized in spines at 0 minutes 
following DHPG removal, indicating the addition of iso1 did not alter the response 
(0.045±0.013 before stimulation versus 0.139±0.025 at 0 minutes after stimulation in WT 
neurons, p<0.05, Fig. 3.4.b). The fraction of CaMKII mRNA in iso1 transfected fmr1 
KO spines was only slightly increased at 10 min after DHPG treatment.  
Interestingly, after introducing pIRES-EGFP-mRFP-iso7 into wild type neurons, we 
found that the fraction of CaMKII localized in spines peaked at 10 minutes after DHPG 
treatment (0.050±0.013 before stimulation versus 0.132±0.022 at 10 minutes after 
stimulation in WT neurons, p<0.05, Fig. 3.4.c) instead of 0 minutes in control group (Fig. 
3.4.a). Again, introduction of iso7 did not restore CaMKII localization in fmr1 KO 
spines either.  
In WT neurons transfected with pIRES-EGFP-mRFP-iso2, there was an elevated fraction 
of CaMKII localized in spines at 0 minutes after DHPG removal (0.062±0.011 before 
stimulation versus 0.133±0.026 at 0 minutes after stimulation in WT neurons, p<0.05, 
Fig. 3.4.d). This may have been contributed by other endogenous FMRP isoforms since 
iso2 does not decelerate efficiently (Fig. 3.2.b in WT neurons). Iso2 did not restore 
CaMKII spine localization in fmr1 KO. The data suggest that a single FMRP isoform, 
which we tested here, is not sufficient to completely restore the activity of synaptic 
mRNA delivery in fmr1 KO neurons to the level of WT. 
 
Discussion 
In this study, we investigated the dynamic motions of four FMRP isoforms and 
determined their sufficiency to target CaMKII mRNA to spines following group I 
mGluR stimulation. We found that phosphorylation modification at serine 499 is critical 
to determine the behavior of FMRP-bearing granules before and after group I mGluR 
agonist stimulation. After stimulation, but only in the presence of other isoforms, iso1 
and iso7 can decelerate efficiently; the speed of iso2 and iso8 did not alter significantly. 
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Although iso1 and iso7 displayed DHPG-induced deceleration of granules, nevertheless, 
when FMRP iso1 and iso7 were introduced to fmr1 KO neurons, CaMKII mRNA was 
not localized to spines at the same level as in WT. These data suggest that the four 
specific isoforms tested here were singly not sufficient to restore FMRP activity in 
synaptic mRNA delivery in fmr1 KO neurons. 
We observed that in proximal dendrites there were also fast-moving small particles, but 
that are difficult to track across frames to measure speed, as reported previously [63, 98]. 
We therefore next used FRAP to measure the kinetics of these small EGFP labeled 
particles, caused by both active transport and diffusion. A higher score for percentage of 
recovery and mobile fraction results from higher motility of small particles moving from 
the non-bleached to the bleached area. The motility of small particles of iso2 and iso8 
(Fig. 3.5.b and d), which do not contain the serine 499 phosphorylation site, elevated 
dramatically upon DHPG stimulation compared to iso1 and iso7 (Fig. 3.5.a and c). This 
might be because before stimulation iso1 and iso7 small particles exhibited greater 
motility than iso2 and iso8. More dynamic FMRP small particles in response to DHPG is 
also consistent with the previous report [63]. The data suggest that phosphorylation 
modification of FMRP is a critical determinant of its kinetics before and after group I 
mGluR stimulation. 
Our data suggested that phosphorylation in serine 499 is critical to determine FMRP 
speed (Fig. 3.2) and kinetics (Fig. 3.5). When there is no serine 499 (iso2 and iso8), 
FMRP cannot decelerate in response to group I mGluR stimulation (Fig. 3.2.b and d). 
The phosphorylation of FMRP is regulated by S6K1 and PP2a [114, 115]. Previously, 
Ceman et al. [41] found that phosphorylation in serine 499 of FMRP could regulate 
FMRP in active or stalled translation elongation state, which could be mediated by 
miRNA pathway [105]. More importantly, phosphorylation of FMRP is also critical to 
regulate synapse number [109]. More studies need to be done to associate 
phosphorylation regulation of FMRP with mRNA docking and translation mechanism. 
We also measured directionality of EGFP labeled isoforms as described previously [113]. 
We found that directionality of iso1, iso2 and iso7 reduced at 0-20 minutes upon DHPG 
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removal only in the presence of other isoforms (in WT neurons, Fig. 3.6). Kosik et al [29] 
have also suggested that one subset of granules oscillates near a cluster of synapses. We 
hypothesized that the slowed motion and enhanced oscillation in response to DHPG 
could result from FMRP targeting and docking to synapses. 
The function of an individual FMRP isoform could be determined by the association with 
its interacting proteins. The motility of dendritic delivery of FMRP isoforms may be 
highly associated with interaction with motor proteins, such as KHC, KIF3C, DHC and 
myosinV, and how that association is regulated by neuronal stimulation [60, 61, 65, 97]. 
The gene product of two autosomal homologues of the FMR1 gene, FXR1 and FXR2, 
can form oligomers with FMRP [116]. Although FXR1P is more highly expressed in 
muscle cells [117, 118], FXR2P has overlapping functions in neurons with FMRP [119, 
120]. CYFIP1/2 (cytoplasmic FMRP interacting proteins) in Drosophila can interact with 
dFMR1 biochemically and genetically to regulate cytoskeleton remodeling downstream 
of Rho GTPase pathway [121, 122]. NUFIP1 (nuclear FMRP interacting protein) and 82-
FIP, two other FMRP associated proteins, are involved in nucleocytoplasmic shuttling 
and cell cycle dependent localization of FMRP, respectively [123-125]. The association 
between any single FMRP isoform and other isoforms and its interacting proteins is 
implicated in individual isoform function.  
The interaction between FMRP isoform and its associated mRNA and polyribosomes will 
also be an important question to answer. FMRP associated mRNAs, such as 
CaMKII[55], PSD-95 [56], and MAP1b [57], are highly involved in synaptic function. 
Whether there is specificity between FMRP isoform and mRNA targets could determine 
if single isoform or multiple isoforms will be required to restore function in fmr1 KO 
neurons. From another perspective, FMRP association with polyribosome is mediated by 
mRNA [52]. The I304M mutation of FMRP disrupts its association with polyribosome 
[126], yet it has not been studied if the splicing of Fmr1 exon12 affects FMRP 
association with polyribosomes. It is conceivable that the specificity between FMRP and 
mRNAs will alter FMRP association with polyribosomes. 
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Our data suggest that the serine 499 phosphorylation site is important to determine the 
speed of FMRP isoforms, which we examined here. More importantly, a single FMRP 
isoform is not sufficient to restore synaptic mRNA targeting function in fmr1 KO in vitro. 
More molecular and biochemical properties of single isoforms will need to be determined 
in the future. The fmr1 KO mouse could be used a model for assessing the roles of 
combined FMRP isoforms, with the eventual goal of patient therapy. 
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Figures 
Figure 3.1 Alternative splicing of Fmr1. 
(a) Alternative splicing affects the presence of exon12 and exon14, and the selective 
usage of splicing acceptors on exon15 and exon17.  
(b) Fmr1 iso1, iso2, iso7 and iso8, on which exon12 and exon15 with corresponding 
phosphorylation site are differentially spliced, were characterized here. FMRP iso1 is the 
full length protein; iso2 does not contain serine 499; iso7 does not have a hydrophobic 
loop extended from KH2; and iso8 does not contain either. 
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Figure 3.2 Speed of EGFP-FMRP isoforms 
(a) In WT neurons, the speed of EGFP-labeled iso1 was significantly reduced at 0-20 
minutes after DHPG stimulation. (b) In fmr1 KO neurons, iso2 was significantly faster 
than in WT neurons at 0-20 minutes after DHPG. (c) In WT neurons, the speed of iso7 
was significantly reduced after DHPG stimulation. (d) Iso8 does not alter speed 
significantly over one hour after DHPG removal. Bar graph represents data from at least 
three independent experiments, total of at least 40 mRNA particles in each group. 
Statistical analysis by two-way ANOVA with Tukey HSD post test. Error bars denote 
SEM. 
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Figure 3.3 Total number of CaMKII puncta whthin every 50 m dendritic 
segment did not change over one hour after group I mGluR stimulation.  
The number of CaMKII mRNA particles in 50μm dendrite segments was calculated in 
WT and fmr1 KO neurons transfected with pIRES-EGFP-mRFP (a), pIRES-EGFP-
mRFP-iso1 (b), pIRES-EGFP-mRFP-iso7 (c), or pIRES-EGFP-mRFP-iso2 (d), before or 
at different time points after 5 min DHPG treatment. There is no difference in the number 
of total RNA puncta among groups. Data were analyzed from at least 18 dendrites in each 
group from three independent experiments. Data were analyzed by two-way ANOVA 
with Tukey-HSD post-test. 
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Figure 3.4 Spine localization of endogenous CaMKIIin fmr1 KO neurons was not 
restored by a single FMRP isoform tested here. 
The fraction of the number of CaMKII mRNA localized in spines versus total number 
of CaMKII in each 50μm dendrite segment was calculated in each group. The data 
showed a peak fraction after DHPG stimulation in WT but not KO transfected with 
pIRES-EGFP-mRFP as a control (a), pIRES-EGFP-mRFP-iso1 (b), pIRES-EGFP-mRFP-
iso7 (c), or pIRES-EGFP-mRFP-iso2 (d). Data were analyzed from at least 18 dendrites 
in each group from three independent experiments. The value of ratio was transformed to 
meet normality requirement and then analyzed by two-way ANOVA with Tukey-HSD. 
Error bars denote SEM. 
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Figure 3.5 Kinetics of isoform by FRAP 
FRAP was measured as percentage recovery after photobleaching, 100% as intensity 
before photobleaching and 0% as intensity after bleaching. Mobile fraction (%) is the 
percentage of recovery at steady state. Before stimulation (control), iso1 and iso7 had 
higher mobile fraction (a, b). In response to DHPG, more iso2 and iso8 became 
mobilized from immobile pools (b, d). Bar graph represents data from three independent 
experiments, at least 6 dendrites in each experiment. Statistical analysis by independent t-
test. Error bars denote SEM. 
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Figure 3.6 Directionality of FMRP isoforms 
(a) In WT neurons, iso1 became oscillating at 0-20 minutes after DHPG treatment. (b, c) 
In only WT neurons, iso2 and iso7 also became more oscillating at 0-20 minutes upon 
DHPG stimulation. (d) Iso8 does not alter its directionality in response to DHPG. Bar 
graph represents data from at least three independent experiments, total of at least 40 
mRNA particles in each group. Statistical analysis by two-way ANOVA with Tukey 
HSD post test. Error bars denote SEM. 
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Chapter 4. 
Conclusions 
My data suggest that FMRP could mediate deceleration of its associated mRNA, along 
with delivery to dendritic spines for local protein synthesis in response to group I mGluR 
stimulation. Synaptic mRNA delivery required the presence of more than one FMRP 
splicing isoform to accomplish the task. The work significantly demonstrated that FMRP 
as an RNA binding protein is involved in the mechanism of synaptic mRNA delivery. 
Synaptic targeting of mRNAs is a critical step to provide materials for local protein 
synthesis in response to stimulation with temporal and spatial accuracy. With the newly 
synthesized proteins, spine structure and synaptic connection strength can be modified in 
the activated synapse. Among about 10,000 synapses in one neuron, the mechanism of 
local mRNA delivery and protein synthesis is the basis for needed spatial specificity. On 
the other hand, if local protein synthesis is dysregulated, synapse connection would be 
abnormally altered, which could cause neurological phenotypes, such as seizures, 
hyperactivity and mental retardation shown in Fragile X syndrome. Therefore, it is very 
important to understand the molecular mechanism underlying synaptic mRNA delivery 
and protein synthesis. 
Although alternative splicing of Fmr1 was reported in 1993 [82], the functional roles of 
various FMRP splicing isoforms have rarely been studied. To understand the possibility 
for gene therapy in Fragile X Syndrome, I have used this tool to explore the synaptic 
mRNA delivery activity of four FMRP isoforms. Phosphorylation modification of FMRP 
is apparently critical to regulate its synaptic docking. However, it will still require the 
presence of more than one FMRP isoform to deliver CaMKII mRNA to dendritic spines 
in response to group I mGluR stimulation. This is perhaps not surprising because one 
synaptic mRNA delivery process would require several events, such as sensing signals, 
determining directionality, association with motor proteins, mRNAs and even scaffolding 
proteins, for anchorage and deposition. And the subsequent translation control will also 
require multiple activities to govern translation initiation or elongation. The diverse 
functions of FMRP isoforms will be important to be elucidated. 
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In conclusion, during my PhD studies, my data suggested that FMRP could mediate 
mRNA synaptic delivery for local protein synthesis, which is likely critical to establish 
and maintain synaptic connections between neurons. And more than one FMRP splicing 
isoform would be likely to be involved in the mechanism of synaptic mRNA delivery. 
The molecular regulation underlying synaptic mRNA delivery for local protein synthesis 
still needs to be further investigated. 
  
65 
 
Appendix A. 
Lithium treatment of fmr1 KO mouse model for Fragile X Syndrome 
 
Abstract 
To examine the anxiolytic effect of lithium administration in fmr1 KO mice, marble 
burying behavior was examined. The fmr1 KO mouse model is present on two 
background strains, FVB and C57BL/6. In the FVB strain, lithium reduced the number of 
buried marbles suggesting that lithium has a general anxiolytic effect in FVB. In 
untreated C57BL/6, fmr1 KO buried more marbles than WT. After lithium treatment the 
number of marbles buried by fmr1 KO mice was significantly reduced to the level of WT. 
Therefore, lithium reversed digging/perseverative behavior in C57BL/6 KO. The assay 
also suggests that the interaction of genetic background and pharmaceutical action could 
affect behavior outcome. 
 
Introduction 
Lithium has been used as a mood stabilizer. It is an FDA approved drug to treat bipolar 
disorder, depression and other mood disorders. The molecular mechanism underlying 
lithium treatment is possibly due to its activity in inositol depletion and GSK3β 
(glycogen synthase kinase-3) inhibition [127-129]. It is able to suppress manic-
depressive episodes and relieve anxiety in bipolar disorder. 
Lithium was shown to improve short term memory in courtship conditioning and spine 
structure deficits in mushroom body in the Drosophila model of Fragile X syndrome 
[130]. However, dFMR1 gene composition is more similar to mammalian FXR2, which is 
one of two autosomal paralogs of FMR1. More recent research in human patients 
supports the usage of lithium in Fragile X Syndrome. Berry-Kravis et al. demonstrated 
that in Fragile X Syndrome patients, lithium treatment could improve the score of 
66 
 
patients on Aberrant Behavior Checklist (an assessment of behavior features among 
mentally retarded individuals) and ERK activation speed to the levels comparable to 
control patient group [131]. The study encourages future investigation of the molecular 
mechanism of lithium action in Fragile X Syndrome. 
Several promising studies of the mechanism of lithium in the fmr1 KO mouse model have 
been published recently. The activity of GSK3, one target of lithium, is elevated in 
several brain regions of fmr1 KO mice. Lithium reduced GSK3b activity and behavioral 
hyperactivity levels (measured by open field center entry behavior and audiogenic 
seizures) in fmr1 KO animals [132]. Fmr1 KO mice displayed altered anxiety level (by 
elevated plus-maze test) and fear motivated memory (by passive avoidance test) and 
impaired social interaction, and these differences were ameliorated by chronic lithium 
treatment [133-135]. Lithium administration partially normalized longer and increased 
density of dendritic spine morphology in fmr1 KO medial prefrontal cortex [133]. These 
positive effects of lithium treatment in Fragile X animal model support further study in 
human patients. 
In addition to cognition impairment, Fragile X syndrome patients are also at risk for 
social anxiety [136]. Previously, elevated social anxiety and impaired social interaction in 
fmr1 KO mice were shown in social novelty test [137]. Marble burying has been a 
convenient test to identify anxiolytics. After treatment with anxiolytics, rodents dig/bury 
fewer marbles. The reason that rodents alter their digging behavior is still unknown. 
Marbles are not aversive because mice did not avoid the marble-containing side of a two-
compartment box [138]. Long term studies suggest that inhibition of marble burying can 
be used as a correlational model for detection of anxiolytics rather than an isomorphic 
model of anxiety [138]. Here, a marble burying test was utilized as an assay system to 
evaluate the lithium effect on anxiety amelioration. 
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Materials and Methods 
Marble burying.  
Clean cages (23x44x15 cm) were filled with 4.5cm corncob bedding, on which 20 dark 
blue glass marbles (15mm diameter) were placed (Fig. A.1.a). Three months old mice 
were habituated for 30 minutes in the behavior room before starting the experiments. One 
animal was placed in each cage and allowed 30 minutes for exploration. After 30 
minutes, the number of marbles buried (to 1/2 surface area) with bedding was counted 
(Fig. A.1.b). 
Chronic lithium administration.  
Fmr1 KO and WT male mice of FVB and C57BL/6 strains were used. The animals were 
bred at the Beckman Institute at the University of Illinois-Urbana-Champaign. Following 
weaning at day 21, mice were housed in same-sex littermate groups in standard 
laboratory cages with a 12 hour light/dark cycle. Food and water were available ad 
libitum. Mice were divided into four groups as WT, WT treated with lithium, KO, and 
KO treated with lithium. Mice had unlimited access to regular chow or chow containing 
0.24% lithium carbonate (Harlan Teklad, Madison, WI, diet no. 92271) with 
supplemental saline (0.9%), beginning from two months old till three months old for 
tests. Measurement of mice serum lithium level was kindly performed by Provena 
Medical Center, Urbana, IL.  Serum lithium level was maintained at 0.73 mmol/L in FVB 
strain and at 0.5 mmol/L in C57BL/6 strain, which are comparable to standard level in 
human patients (0.6~ 1.2 mmol/L). Experimental procedures were approved by the 
Institutional Animal Care and Use Committee at UIUC. 
 
Results 
To investigate anxiolytic effect of lithium administration in fmr1 KO animals, marble 
burying behavior was examined in WT and fmr1 KO mice after lithium treatment. Two 
available mouse strains, FVB and C57BL/6, were both tested because distinct genetic 
background could account for behavioral differences [139]. Mice in the lithium group 
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started receiving 0.24% lithium carbonate mixed in regular chow when two months old; 
after one month of chronic lithium administration, serum lithium level and the marble 
burying behavior were examined. To avoid lithium toxicity, serum lithium levels were 
measured and appeared slightly different in two mouse strain: 0.73 mmol/L in FVB and 
0.5 mmol/L in C57BL/6. This suggests that the genetic background does affect how 
lithium is metabolized and maintained in animals. And both lithium levels were 
comparable to standard level in human patients (0.6~1.2 mmol/L).  
In the FVB strain, there is no significant difference between WT and KO genotypes (Fig. 
A.2.a). However, there is a significant effect of lithium treatment (10.1±0.6 marbles in 
control group and 8.2±0.6 marbles in lithium group, p<0.05). Therefore, lithium has a 
general anxiolytic effect in FVB.  
In C57BL/6 (Fig. A.2.b), WT and KO exhibited different marble burying behavior in 
response to lithium (interaction, p<0.05). In the control group, KO exhibited significantly 
higher marble burying activity than WT (10.3±0.9 marbles in control KO group versus 
6.1±1.2 marbles in control WT group, p<0.05). After lithium treatment, WT persisted in a 
similar level of burying behavior (5.5±1.0 marbles in lithium treated WT group). But in 
C57BL/6 KO, the number of buried marbles was significantly reduced after chronic 
lithium treatment (4.3±1.5 marbles in lithium treated KO group, p<0.05). These results 
suggest that chronic lithium treatment is able to decrease marble burying behavior, as an 
assessment of anxiolytics, in C57BL/6 fmr1 KO. 
 
Discussion 
We concluded that lithium can relieve anxiety in fmr1 KO of C57BL/6 but not in FVB by 
using the marble burying test to assess the anxiolytic effect of lithium. Interestingly, there 
is elevated level of marble burying behavior in fmr1 KO of only C57BL/6 background, 
but not in FVB background. It suggests that the interaction of genetic background and 
chronic lithium treatment results in different effects in marble burying test. It has been 
previously reported that different mouse genetic backgrounds indeed influence various 
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behavior tests [139]. The results are applicable to human patients, in that human 
populations with different genetic backgrounds may require different pharmaceutical 
treatment. 
Anxiety was measured in fmr1 KO mice using the elevated plus maze but the results were 
controversial. In some reports, fmr1 KO performed as well as WT animals in elevated 
plus maze [140, 141]. But in others, fmr1 KO performed poorly in elevated plus maze 
and the performance could be restored by several drugs [133, 135, 142]. The discrepancy 
could be caused by the difference in experiment designs but not strain difference. 
Therefore, our data here could provide another assessment of anxiety deficit and possible 
anxiolytics in Fragile X Syndrome model. 
Although marble burying test has been widely utilized as a model for anxiety or 
obsessive compulsive disorder (OCD), its physiological relevance is still controversial. 
Compounds antagonizing serotonin (5-HT) or mGluR5 system, many of which attenuate 
anxiety, depression or OCD, also inhibited marble burying [143-146].  Since then marble 
burying has been used as a standard test for anxiety and depression drug discovery. 
However, Deacon et al. suggested that the marble burying test may best be considered as 
a species typical behavior that is responsive to many factors since many agents, even 
psychostimulants, inhibit marble burying behavior [147]. In recent research by Thomas 
and Paylor et al, it was found that mouse marble burying is not correlated with other 
anxiety-like traits, not stimulated by novelty, but a repetitive behavior that 
persists/perseveres with little change across multiple exposures. They also suggested that 
marble burying is related to repetitive digging behavior and may in fact be more 
appropriately considered as an indicative measure of perseverative behavior [148]. For 
future studies in the lab, we should consider marble burying test as a measurement of 
repetitive digging, which also responds to anxiolytics. 
Polyuria (increased urine production) is the most prominent side effect in lithium treated 
human patients. We observed the same effect in mice. Therefore, mouse bedding was  
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always changed twice a week in contrast to once per week before treatment. We did not 
observe other side effects of lithium over-dosage, such as diarrhea, seizures and coma, in 
mice. 
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Figures 
Figure A.1 Marble burying test apparatus  
(a) 20 marbles were spaced evenly in a cage filled with corncob bedding before the test. 
(b) After 30 minutes exploration, marbles were buried or moved by the mouse. The 
number of buried marbles was recorded.  
a. 
 
b. 
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Figure A.2 Effect of administration of lithium on the marble-burying behavior in (a) 
FVB and (b) C57BL/6 mice.  
Each column represents mean± S.E.M. of number of marbles buried in each group. The 
number of mice in each group is labeled on each column.  
a. 
 
b. 
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